Retinal Progression Biomarkers of Early and Intermediate Age-Related Macular Degeneration
Early and intermediate AMD patients represent a heterogeneous population with an important but variable risk of progression to more advanced stages of the disease. The five-year progression from early and intermediate AMD to late disease is known to range from 0.4% to 53%. This wide variation explai...
Autor principal: | |
---|---|
Outros Autores: | , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2022
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10400.17/4346 |
País: | Portugal |
Oai: | oai:repositorio.chlc.min-saude.pt:10400.17/4346 |